Company news
Helix Biopharma Corp. (TSX:HBP) news
Helix Biopharma Corp. news releases on 6ix. Latest, Aug 31, 2020: Helix BioPharma Corp. Provides Polish Subsidiary Divestiture Update
Press releases — page 3
Helix BioPharma Corp. Provides Polish Subsidiary Divestiture Update
August 31, 2020
Helix BioPharma Corp. and Moffitt Cancer Center Extend Immunotherapy Collaboration
August 12, 2020
49 Public Companies to Present at the SNN Network Virtual Conference on August 3-6, 2020
August 3, 2020
Helix BioPharma Corp. to Present at the SNN Network Virtual Conference
July 31, 2020
Helix BioPharma Corp. to Present at Alpha Bronze Virtual Town Hall
July 27, 2020
Helix BioPharma Corp. Opens the Market
May 26, 2016
Helix BioPharma Approved for NYSE Amex Listing
September 14, 2010
Helix BioPharma Closes $11.0 Million Private Placement
August 6, 2010
Helix BioPharma Corp. Announces Positive Phase II Pharmacokinetic Findings for Topical Interferon Alpha-2b in Patients With Low-Grade Cervical Lesions
June 23, 2010
Helix BioPharma Corp. Announces Fiscal Q3 2010 Results
June 11, 2010
Helix BioPharma Corp Announces Phase II Clinical Trial Results of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
June 8, 2010
Helix BioPharma to Present at the BioFinance 2010 Conference on April 7
April 5, 2010
TSX in red at noon
March 22, 2010
TSX goes south
March 22, 2010
Helix BioPharma Corp Achieves Last-Patient-Out in Its Phase II Trial of Topical Interferon Alpha-2b in Patients with Ano-Genital Warts
March 22, 2010
Slight gains for TSX
March 10, 2010
Helix BioPharma to Present at 7th Annual BIO Asia Partnering Conference on January 26
January 22, 2010
Helix BioPharma To Present at Biotech Showcase(TM) 2010 on January 13
January 7, 2010
Helix BioPharma Reports On 2009 Annual General Meeting
December 9, 2009
Helix BioPharma Corp. Announces Fiscal Q1 2010 Results
December 9, 2009
Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th
November 6, 2009
Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
November 5, 2009
Helix BioPharma Corp. Announces Fiscal 2009 Results
October 29, 2009
Helix BioPharma's L-DOS47 to be Highlighted at Pharmaceutical Industry Conference
October 14, 2009
Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
October 6, 2009
Helix BioPharma Closes Private Placement
September 8, 2009
Helix BioPharma Announces $13.5 Million Private Placement
September 4, 2009
Helix Biopharma to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
September 3, 2009
Helix BioPharma Announces the Appointment of Kazimierz Roszkowski-Sliz, M.D., Ph.D., to its Board of Directors
August 17, 2009
Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF
June 23, 2009
Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference
June 19, 2009
Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
June 15, 2009
Helix BioPharma to Present at the BioFinance 2009 Conference
April 24, 2009
Helix BioPharma Announces Q2 2009 Financial Results
March 16, 2009
Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
March 16, 2009
Helix BioPharma Form 20-F Registration Statement Declared Effective by SEC
March 12, 2009
Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update
December 16, 2008
Helix BioPharma Announces Q1 2009 Financial Results
December 11, 2008
Helix BioPharma Files Form 20-F Registration Statement With the U.S. Securities and Exchange Commission
November 25, 2008
Helix BioPharma Presents Preclinical L-DOS47 Data at The Second Conference of Lung Cancer in Warsaw, Poland
November 19, 2008
Helix BioPharma Corp. Announces Fiscal 2008 Results
October 28, 2008
Helix Biopharma Closes $11.4 Million Private Placement
October 2, 2008
Helix BioPharma Announces $11.4 Million Private Placement
September 30, 2008
Helix BioPharma product development update, quarterly highlights and financial results for fiscal Q3 2008
June 11, 2008
W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
April 7, 2008
Helix BioPharma reports Q2 2008 highlights, financial results
March 10, 2008
Helix BioPharma shareholders vote in favour of management
January 30, 2008
Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
January 16, 2008
Helix BioPharma closes $16.9 million private placement of common shares
December 19, 2007
Helix BioPharma announces Q1 2008 financial results
December 17, 2007